Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-043974

Chief Operating Officer sold 1,714 shares at $41.23 ($70,668)

  • Chief Operating Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bruno Julianne Chief Operating Officer 2025-03-20 Option exercise +3,750 12,258 D
Bruno Julianne Chief Operating Officer 2025-03-21 Sale −1,714 $41.23 $70,668 10,544 D
Derivatives
Bruno Julianne Chief Operating Officer 2025-03-20 Option exercise · Restricted Stock Units −3,750 11,250 D
Open-market sales · 1,714 sh · avg $41.23 · $70,668
Loading xslF345X05/ownership.xml…